Broadening Cancer Screening with WES

A retrospective analysis of data from the Mayo Clinic's Tapestry trial shows that whole-exome sequencing is an effective tool to identify people with hereditary breast and ovarian cancer syndrome and Lynch syndrome. The study also revealed that nearly 40% of these people, despite their cancer risk, would not qualify for preventive screening under current National Comprehensive Cancer Network guidelines.